Risks of more device, drug price cuts loom as French pares down healthcare spending
This article was originally published in Clinica
Executive Summary
The French parliament has passed a package of measures including proposals to slice €10bn of healthcare spending over the 2015-17 period, €3.5bn of which will affect medicines, and probably medical devices, in the form of selected price cuts.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.